These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35283250)
1. Heart failure in adults with congenital heart disease. Brida M; Lovrić D; Griselli M; Riesgo Gil F; Gatzoulis MA Int J Cardiol; 2022 Jun; 357():39-45. PubMed ID: 35283250 [TBL] [Abstract][Full Text] [Related]
2. Systemic Right Ventricle in Adults With Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management. Brida M; Diller GP; Gatzoulis MA Circulation; 2018 Jan; 137(5):508-518. PubMed ID: 29378757 [TBL] [Abstract][Full Text] [Related]
3. Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium-glucose co-transporter 2 inhibitors? Berezin AE; Berezin AA Future Cardiol; 2021 May; 17(3):497-506. PubMed ID: 33615880 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis. Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582 [TBL] [Abstract][Full Text] [Related]
5. Mechanical Support of the Failing Fontan Circulation. Mascio CE Semin Thorac Cardiovasc Surg; 2021 Summer; 33(2):454-458. PubMed ID: 32977017 [TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy in adults with congenital heart disease. Koyak Z; de Groot JR; Krimly A; Mackay TM; Bouma BJ; Silversides CK; Oechslin EN; Hoke U; van Erven L; Budts W; Van Gelder IC; Mulder BJM; Harris L Europace; 2018 Feb; 20(2):315-322. PubMed ID: 28108550 [TBL] [Abstract][Full Text] [Related]
7. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464 [TBL] [Abstract][Full Text] [Related]
8. Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure. Van De Bruaene A; Hickey EJ; Kovacs AH; Crean AM; Wald RM; Silversides CK; Redington AN; Ross HJ; Alba AC; Billia F; Nair K; Benson L; Horlick E; Osten M; Colman J; Heggie J; Oechslin EN; Roche SL Int J Cardiol; 2018 Feb; 252():80-87. PubMed ID: 29103857 [TBL] [Abstract][Full Text] [Related]
9. General principles of heart failure management in adult congenital heart disease. Tompkins R; Romfh A Heart Fail Rev; 2020 Jul; 25(4):555-567. PubMed ID: 31788738 [TBL] [Abstract][Full Text] [Related]
10. Incidence and Outcomes of Advanced Heart Failure in Adults With Congenital Heart Disease. Egbe AC; Miranda WR; Jain CC; Bonnichsen CR; Anderson JH; Dearani JA; Warnes CA; Crestanello J; Connolly HM Circ Heart Fail; 2022 Dec; 15(12):e009675. PubMed ID: 36193744 [TBL] [Abstract][Full Text] [Related]
11. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure. Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700 [TBL] [Abstract][Full Text] [Related]
12. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. O'Meara E; McDonald M; Chan M; Ducharme A; Ezekowitz JA; Giannetti N; Grzeslo A; Heckman GA; Howlett JG; Koshman SL; Lepage S; Mielniczuk LM; Moe GW; Swiggum E; Toma M; Virani SA; Zieroth S; De S; Matteau S; Parent MC; Asgar AW; Cohen G; Fine N; Davis M; Verma S; Cherney D; Abrams H; Al-Hesayen A; Cohen-Solal A; D'Astous M; Delgado DH; Desplantie O; Estrella-Holder E; Green L; Haddad H; Harkness K; Hernandez AF; Kouz S; LeBlanc MH; Lee D; Masoudi FA; McKelvie RS; Rajda M; Ross HJ; Sussex B Can J Cardiol; 2020 Feb; 36(2):159-169. PubMed ID: 32036861 [TBL] [Abstract][Full Text] [Related]
13. A review of heart failure in adults with congenital heart disease. Parekh DR Methodist Debakey Cardiovasc J; 2011; 7(2):26-32. PubMed ID: 21685844 [TBL] [Abstract][Full Text] [Related]
17. Updates in the management of congenital heart disease in adult patients. Massarella D; Alonso-Gonzalez R Expert Rev Cardiovasc Ther; 2022 Sep; 20(9):719-732. PubMed ID: 36128784 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and management of heart failure in repaired congenital heart disease. Kantor PF; Redington AN Heart Fail Clin; 2010 Oct; 6(4):497-506, ix. PubMed ID: 20869649 [TBL] [Abstract][Full Text] [Related]
19. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial. Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837 [TBL] [Abstract][Full Text] [Related]
20. The epidemiology of heart failure in adults with congenital heart disease. Rodriguez FH; Marelli AJ Heart Fail Clin; 2014 Jan; 10(1):1-7. PubMed ID: 24275290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]